Key Points
- COO John Gallagher sold 430 shares of Trupanion (NASDAQ:TRUP) on Dec. 29 at an average price of $37.55 for $16,146.50, trimming his position by 1.31% to 32,291 shares (≈$1.21M).
- Trupanion reported $0.13 EPS on Nov. 6—missing estimates by $0.76—while revenue rose 12% year-over-year to $366.92 million.
- TRUP opened at $38.17, has a market cap of about $1.65 billion and a PE around 106; analysts hold a consensus "Hold" with an average target price of $52.25 and mixed ratings.
Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) COO John Gallagher sold 430 shares of the business's stock in a transaction on Monday, December 29th. The shares were sold at an average price of $37.55, for a total transaction of $16,146.50. Following the transaction, the chief operating officer directly owned 32,291 shares of the company's stock, valued at approximately $1,212,527.05. This trade represents a 1.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Trupanion Stock Up 1.1%
TRUP stock opened at $38.17 on Wednesday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.31. Trupanion, Inc. has a fifty-two week low of $31.00 and a fifty-two week high of $57.88. The firm's 50-day simple moving average is $38.18 and its 200 day simple moving average is $44.33. The stock has a market cap of $1.65 billion, a PE ratio of 106.03 and a beta of 1.62.
Trupanion (NASDAQ:TRUP - Get Free Report) last posted its earnings results on Thursday, November 6th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.89 by ($0.76). Trupanion had a net margin of 1.10% and a return on equity of 4.48%. The firm had revenue of $366.92 million for the quarter, compared to analyst estimates of $361.58 million. During the same period in the previous year, the firm earned $0.03 earnings per share. The company's revenue for the quarter was up 12.0% on a year-over-year basis. As a group, sell-side analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.
Institutional Trading of Trupanion
Institutional investors have recently modified their holdings of the company. Tudor Investment Corp ET AL boosted its stake in Trupanion by 183.7% during the third quarter. Tudor Investment Corp ET AL now owns 237,125 shares of the financial services provider's stock valued at $10,263,000 after buying an additional 153,530 shares in the last quarter. Saranac Partners Ltd bought a new position in shares of Trupanion during the 3rd quarter valued at about $1,070,000. CIBC Bancorp USA Inc. acquired a new position in shares of Trupanion in the 3rd quarter worth approximately $367,000. Advisory Services Network LLC acquired a new position in shares of Trupanion in the 3rd quarter worth approximately $160,000. Finally, OmniStar Financial Group Inc. bought a new stake in shares of Trupanion in the 3rd quarter worth approximately $272,000.
Wall Street Analyst Weigh In
TRUP has been the topic of several analyst reports. Weiss Ratings restated a "sell (d+)" rating on shares of Trupanion in a research report on Monday. Stifel Nicolaus lowered their price target on Trupanion from $45.00 to $42.00 and set a "hold" rating on the stock in a report on Tuesday, November 18th. Piper Sandler reduced their price objective on shares of Trupanion from $67.00 to $60.00 and set an "overweight" rating for the company in a report on Friday, December 19th. Finally, Wall Street Zen cut shares of Trupanion from a "buy" rating to a "hold" rating in a research note on Saturday, December 6th. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $52.25.
Read Our Latest Research Report on TRUP
About Trupanion
(
Get Free Report)
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
